Findings from three studies presented at the recent 84th American Diabetes Association (ADA) Scientific Sessions, held in Orlando, Florida, from June 21 to 24, showcased the latest developments in treatments for obesity, including GLP-1 (Glucagon-like peptide-1) receptor agonists
and (iii) standardized, reproducible scale-up manufacturing protocols that meet Good Manufacturing Practice (GMP) standards
Using density functional theory calculations, the catalytic cycle of the ruthenium catalyst was predicted
Nat Commun (2021) 12(1):213
Biochem Biophys Res Commun 290:4752 Lee JW, Miyawaki H, Bobst EV et al (1999) Improved functional recovery of ischemic rat hearts due to singlet oxygen scavengers histidine and carnosine
Integrating metabolic care into psychiatric care